Precision Medicine Market Growth – at a CAGR of 10.3% During Forecast Period 2019-2027

Rising awareness about importance of predictive diagnostic testing, increasing geriatric population and increasing focus on reducing treatment expenses are some key factors expected to drive global market revenue growth 

Emergen Research has published its latest report titled, “Precision Medicine Market By Technology (Bioinformatics, Big Data Analytics, Drug Discovery, Companion Diagnostics, Gene Sequencing, Others), By End Use (Pharmaceutical Companies, Diagnostic Companies, Healthcare IT companies, Others), By Application, and By Region Forecasts to 2027”

According to Emergen Research, the global precision medicine market size was USD 60.33 billion in 2019 and is expected to reach USD 132.66 billion in 2027 and register a revenue CAGR of 10.3% during the forecast period. 

Market Dynamics: 

Precision medicine, also called personalized medicine is a new frontier for healthcare that alters individual patient treatment and drugs depending on genetic makeup, environment, and lifestyle. It focuses on creating novel drugs from individuals, rather than a cure-all medicine by analyzing a patient’s medical and genetic history. Precision medicine is significantly gaining traction for disease prevention, management, and enhancing patient outcomes. One of the factors surging demand for personalized medications is the rising prevalence of cancer, cardiovascular and neurological diseases across the globe.

Click Here to Access Free sample PDF Copy of the Report@

Other factors such as increasing awareness about precision medicine, increasing number of product approvals, development of novel therapeutics, gene therapy, next-generation sequencing, rising drug approvals, and favorable government initiatives are expected to fuel global market growth during the forecast period. In addition, ongoing developments in the IT sector and big data analysis, increasing funds by private and public organizations, and increasing pharmaceutical and diagnostic companies worldwide are expected to fuel global market growth to a certain extent during the forecast period. However, high cost of precision medicine and genetic testing, lack of awareness about precision medicine practices, limited access to advanced healthcare and research facilities in many developing economies, and stringent regulatory norms are factors that can hamper overall market growth during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Drug Discovery Segment Register Highest Revenue Growth: 

The drug discovery segment is expected to register highest revenue growth during the forecast period. This can be attributed to factors such as increasing prevalence of cancer, cardiovascular diseases and neurological disorders, increasing need for developing novel drugs, and rising demand for precision medicine. 

Oncology Segment to Account for Largest Revenue Share:

The oncology segment is expected to account for largest revenue share over the forecast period. Increasing prevalence of various cancer types across the globe, rising investments and funds in cancer research, high usage of precision medicine in oncology, and government initiatives to support precision medicine and software applications are expected to drive revenue growth of the segment between 2020 and 2027. 

Looking for Discount [Click on the link] @

North America to Lead in Terms of Revenue Share: 

North America is expected to account for largest revenue share in the global market during the forecast period owing to increasing prevalence of cancer and genetic diseases, high healthcare spending, and presence of leading companies. Other factors such as rising demand for customized medicine, rapid advancements in diagnostic techniques and presence of state-of-art healthcare infrastructure, and increasing focus on developing innovative and affordable procedures are expected to boost North America market growth during the forecast period.  

Major Companies in the Market Include:

  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Quest Diagnostics
  • Qiagen
  • Teva Pharmaceutical
  • Eagle Genomics
  • Novartis
  • Pfizer

For the purpose of this report, Emergen Research has segmented into the global precision medicine market on the basis of technology, end use, application, and region:

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

End Use Outlook (Revenue, USD Billion; 2017-2027)

  • Pharmaceutical Companies
  • Diagnostic Companies
  • Healthcare IT companies
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Oncology
  • Immunology
  • CNS
  • Respiratory
  • Others

Have a look at Report Description and Table of Contents of Market Report@

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Explore Similar Reports offered by Emergen Research:

The Global Surface Treatment Chemicals Market size was valued at USD 12.76 Billion in 2019 and is anticipated to reach USD 19.90 Billion by 2027 at a CAGR of 6.0%. The demand for surface treatment chemicals is used extensively in the production industries.

The global 3D printing plastic Market size was valued at USD 775.3 Million in 2019 and is forecasted to reach USD 4,480.0 Million by 2027 at a CAGR of 24.3%. The 3D printing plastic market is observing an accelerated growth rate attributed to its increasing demand in aerospace & defense, healthcare, automotive, and electronics industries.

The Global Anti Fingerprint Coatings Market size was valued at USD 779.9 Million in 2019 and is anticipated to reach USD 1,297.8 Million by 2027 at a CAGR of 7.1%. The anti-fingerprint coating market is experiencing a surge in demand due to the growing application in automotive, building and construction, consumer goods, and solar panels.

The Global Needle Coke Market size was valued at USD 3.65 Billion in 2019 and is anticipated to reach USD 5.88 Billion by 2027 at a CAGR of 6.5%. Needle coke is witnessing an increased demand owing to its properties, such as small resistivity, good anti-oxidation property, and excellent resistance to impact.

The Global Explosion Proof Equipment Market size was valued at USD 7.20 Billion in 2019 and is anticipated to reach USD 10.77 Billion by 2027 at a CAGR of 5.5%. The explosion-proof equipment market is expected to grow significantly due to the increasing need to improve industrial areas' safety.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@

Read Our Blog@





Back to news